These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 36423429)
1. β-Hydroxybutyrate alleviates pyroptosis in MPP Jiang Z; Yin X; Wang M; Wang Y; Li F; Gao Y; Han G; Gao Z; Wang Z Int Immunopharmacol; 2022 Dec; 113(Pt B):109451. PubMed ID: 36423429 [TBL] [Abstract][Full Text] [Related]
2. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells. Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301 [TBL] [Abstract][Full Text] [Related]
3. Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson's Disease. Zheng R; Ruan Y; Yan Y; Lin Z; Xue N; Yan Y; Tian J; Yin X; Pu J; Zhang B J Inflamm Res; 2021; 14():3063-3075. PubMed ID: 34267535 [TBL] [Abstract][Full Text] [Related]
4. [Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells]. Huang H; Gao Y; Nie K; Wang L Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):972-979. PubMed ID: 34308845 [TBL] [Abstract][Full Text] [Related]
5. Qiji Shujiang granules alleviates dopaminergic neuronal injury of parkinson's disease by inhibiting NLRP3/Caspase-1 pathway mediated pyroptosis. Huan P; Sun X; He Z; Yang S; Wang X; Xie H; Wang L; He J Phytomedicine; 2023 Nov; 120():155019. PubMed ID: 37657208 [TBL] [Abstract][Full Text] [Related]
6. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome. Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454 [TBL] [Abstract][Full Text] [Related]
7. Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis. Zhang X; Zhang Y; Li R; Zhu L; Fu B; Yan T Aging (Albany NY); 2020 May; 12(10):9405-9426. PubMed ID: 32432571 [TBL] [Abstract][Full Text] [Related]
8. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072 [TBL] [Abstract][Full Text] [Related]
9. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation. Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963 [TBL] [Abstract][Full Text] [Related]
10. Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/caspase-1/GSDMD Pathway in MPTP Induced Mice Model of Parkinson's Disease. Rui W; Li S; Xiao H; Xiao M; Shi J Int J Neuropsychopharmacol; 2020 Aug; 23(11):762-73. PubMed ID: 32761175 [TBL] [Abstract][Full Text] [Related]
11. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370 [TBL] [Abstract][Full Text] [Related]
12. Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide. Wang K; Lu C; Wang T; Qiao C; Lu L; Wu D; Lu M; Chen R; Fan L; Tang J Neurochem Int; 2022 Jan; 152():105254. PubMed ID: 34883151 [TBL] [Abstract][Full Text] [Related]
13. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model. Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198 [TBL] [Abstract][Full Text] [Related]
14. Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease. Qiao C; Dang T; Zhou Y; Zhou YZ; Zhao R; Wang M Brain Behav; 2022 Nov; 12(11):e2784. PubMed ID: 36199191 [TBL] [Abstract][Full Text] [Related]
15. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease. Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849 [TBL] [Abstract][Full Text] [Related]
17. Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration. Ma X; Hao J; Wu J; Li Y; Cai X; Zheng Y Adv Mater; 2022 Apr; 34(15):e2106723. PubMed ID: 35143076 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model. Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472 [TBL] [Abstract][Full Text] [Related]
19. Ketone Body β-Hydroxybutyric Acid Ameliorates Dopaminergic Neuron Injury Through Modulating Zinc Finger Protein 36/Acyl-CoA Synthetase Long-Chain Family Member Four Signaling Axis-Mediated Ferroptosis. Yu X; Yang Y; Zhang B; Han G; Yu J; Yu Q; Zhang L Neuroscience; 2023 Jan; 509():157-172. PubMed ID: 36435477 [TBL] [Abstract][Full Text] [Related]
20. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]